StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
1314.TW$7.10+0.85%
Fair $7.10+0.0%

1314.TW

China Petrochemical Development Corporation

Basic Materials / Specialty ChemicalsTaiwan

$7.10

+0.06 (+0.85%)

Fairly Valued+0.0%Fair Value $7.10Fund rank 25/100 · Data gapFallback financials|
SA 14/F
F-Score: 1/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 21%

FCF escenarios

weak_data · normalized FCF $-4.3B · quality 56.7/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 18/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

14/100

F

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is -3.9%, below the 5% threshold
Thesis & Journal · 1314.TWLocal privado en este navegador · China Petrochemical Development Corporation
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$26.9B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-3.9%

↓

Gross Margin

-9.6%

↓

Debt/Equity

0.53

↑
52-Week Range$7
$6$11

TradingView lightweight chart

1314.TW price, volumen y niveles de valoración

Último $7.100Periodo -29.9%
Fair value: $7.100

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-8.4%

FCF CAGR

—

FCF margin

-22.5%

FCF / Net income

1.46x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $19.22B · net income $-2.97B · FCF $-4.33B

2022-FY → 2025-FY

Gross margin

-9.6%-4.6% pts

Operating margin

-18.6%-3.2% pts

Net margin

-15.4%-16.4% pts

FCF margin

-22.5%+27.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$19.22B$19.22B$29.37B$25.44B$25.03B
Net Income$-2.97B$-2.97B$247.7M$-1.06B$233.1M
EBITDA$-447.6M$-447.6M$3.13B$1.70B$2.48B
EPS——0.07-0.280.06
Gross Margin-9.6%-9.6%0.9%-4.4%-4.9%
Operating Margin-18.6%-18.6%-5.8%-11.8%-15.4%
Net Margin-15.4%-15.4%0.8%-4.2%0.9%
Balance Sheet
Debt/Equity0.530.530.560.650.60
Current Ratio1.541.54———
Cash Flow
Free Cash Flow$-4.33B$-4.33B$-3.07B$-5.98B$-12.43B
Returns
ROE-3.9%-3.9%0.3%-1.3%0.3%
Valuation
P/E——102.14—165.50
EV/EBITDA——20.8449.0031.63
P/B0.350.350.340.470.47
Growth & Yield
Revenue Growth-34.6%-34.6%15.4%1.7%—
EPS Growth——125.0%-566.7%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -2.9%

Total return

-2.9%

Start / end P/E

n/dx → n/dx

EPS bridge

0.07 → n/d

Residual

-2.9%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-2.9%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.